Skip to main content

Lithium Hydroxide

Type of Posting: Revision Bulletin

Posting Date: 29–Dec–2011

Official Date: 01–Jan–2012

Expert Committee: Monographs—Small Molecules 4

Reason for Revision: Compliance

In accordance with the Rules and Procedures of the 2010–2015 Council of Experts, the Monographs—Small Molecules 4 Expert Committee has revised the Lithium Hydroxide monograph. The purpose for the revision is to widen the specification for Lithium content from “28.4%–29.1%” to “28.1%–29.9%” to accommodate the sponsor's FDA-approved specifications.

The Lithium Hydroxide Revision Bulletin supersedes the currently official Lithium Hydroxide monograph. The Revision Bulletin will be incorporated in the Second Supplement to USP 35–NF 30.

Should you have any questions, please contact Hari Ramanathan, M.S. (301-816-8313 or hr@usp.org).